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Introduction
Mitochondrial diseases are caused by mutations that affect genes
encoded in both the mitochondrial and nuclear genomes. The
pathological phenotypic outcomes of mitochondrial diseases are
very complex and include blindness, deafness, epilepsy, heart
disease, and muscle and neurological disorders. Although much is
known about the associated mutations, the relationship between
genotype and phenotype is complicated and poorly understood.
Surprisingly, the same genetic defect can result in different
symptoms, and conversely, similar outcomes can be caused by
different genetic lesions (Debray et al., 2008; DiMauro and Schon,
2008).
Among mitochondrial diseases, deficiencies in complex I (CI)
are very relevant in human pathology because about 40% of
mitochondrial OXPHOS diseases involve complex I defects, and
the molecular cause of this deficiency is unknown in many patients
(Janssen et al., 2006; Lazarou et al., 2009). Most cellular ATP is
generated by the mitochondria through aerobic respiration.
Together with complex III and complex IV, CI contributes to the
generation of a proton gradient across the mitochondrial inner
membrane. This proton gradient is used by the ATP synthase
(complex V) for ATP production. Mitochondrial CI (NADH:
ubiquinone oxidoreductase, EC 1.6.5.3) is a huge multiprotein
complex of 45 subunits in mammals. Of the five major respiratory
complexes, CI is the least understood, partly because of its large
size and complexity. Accordingly, it is believed that new
components involved in the assembly, stability and/or activity of
CI still remain to be identified (Koopman et al., 2010; Remacle et
al., 2008).
Extensive post-translational modifications of complex I subunits
have been described, most of which affect the N-termini. Examples
include the loss of mitochondrial import sequences and N-alpha-
acetylation. Phosphorylation in several CI subunits has also been
described to affect CI function. Mutational analysis of the
phosphorylation sites of NDUFA1 and NDUFB11 revealed defects
in CI assembly (Koopman et al., 2010). The presence of methylation
in two CI subunits has also been previously described, although
the functional relevance and the methyltransferase responsible are
not yet known (Carroll et al., 2005; Fearnley et al., 2007; Wu et
al., 2003). In contrast to N-alpha-acetylation, which appears to be
a permanent modification, and similarly to phosphorylation, protein
methylation might be reversible by demethylases and might have
a regulatory role.
The social amoeba Dictyostelium discoideum is a useful model
for the study of biological issues that are relevant to human disease,
including mitochondrial dysfunction (Annesley and Fisher, 2009a;
Barth et al., 2007; Bokko et al., 2007; Chida et al., 2004; Kotsifas
et al., 2002; Torija et al., 2006b; Williams et al., 2006).
Dictyostelium cells feed on bacteria and remain in the form of
individual cells while food is present. However, when the supply
of bacteria is exhausted, starvation triggers a remarkable process
of cellular chemotaxis, allowing the formation of cell aggregates.
These aggregates differentiate to form phototactic migrating slugs
that eventually give rise to fruiting bodies containing spores that
allow Dictyostelium to survive (Escalante and Vicente, 2000). This
developmental program is sensitive to mitochondrial dysfunction,
and slug phototaxis and thermotaxis in particular are affected by
diverse mitochondrial defects (Annesley and Fisher, 2009b;
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Summary
Dictyostelium and human MidA are homologous proteins that belong to a family of proteins of unknown function called DUF185.
Using yeast two-hybrid screening and pull-down experiments, we showed that both proteins interact with the mitochondrial complex
I subunit NDUFS2. Consistent with this, Dictyostelium cells lacking MidA showed a specific defect in complex I activity, and
knockdown of human MidA in HEK293T cells resulted in reduced levels of assembled complex I. These results indicate a role for
MidA in complex I assembly or stability. A structural bioinformatics analysis suggested the presence of a methyltransferase domain;
this was further supported by site-directed mutagenesis of specific residues from the putative catalytic site. Interestingly, this complex
I deficiency in a Dictyostelium midA– mutant causes a complex phenotypic outcome, which includes phototaxis and thermotaxis
defects. We found that these aspects of the phenotype are mediated by a chronic activation of AMPK, revealing a possible role of
AMPK signaling in complex I cytopathology.
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Wilczynska et al., 1997). Moreover, Dictyostelium, as opposed to
the yeast model Saccharomyces cerevisiae, contains all the essential
CI subunits (Eichinger et al., 2005; Ogawa et al., 2000).
Traditionally, it has been assumed that mitochondrial diseases
mediate their effects on the phenotype through the reduced
availability of ATP. However, recent studies in Dictyostelium
suggest that some symptoms might be the consequence of abnormal
regulation of signaling pathways. The relationship between AMP-
activated protein kinase (AMPK), a master regulator of the energy
status of the cell, and mitochondrial diseases has been recognized
recently using Dictyostelium as an experimental model (Bokko et
al., 2007). Previous studies suggest that a chronic activation of
AMPK might be a key element in some of the observed phenotypes
that are present in mitochondrial dysfunction (Barth et al., 2007).
Recently, we described the identification and initial
characterization of a new mitochondrial protein conserved between
Dictyostelium and humans that we named MidA (for mitochondrial
dysfunction protein A) (Torija et al., 2006a; Torija et al., 2006b).
This protein belongs to an uncharacterized conserved protein family
(DUF185 or COG1565). It shows high similarity to the human
protein of unknown function LOC55471 encoded on chromosome
2 (C2orf56 or PRO1853).
Dictyostelium midA– cells showed reduced levels of ATP and a
wide array of phenotypes, including slow growth and abnormal
development. In this report, we have further analyzed the function
of this mitochondrial protein using an integrated approach of
bioinformatics and molecular genetics in Dictyostelium and human
cell culture. The loss of MidA generated a mitochondrial
dysfunction that specifically affected CI activity and the levels of
the fully assembled complex. Moreover, both Dictyostelium and
human MidA proteins interact with NDUFS2, an essential CI core
subunit. The molecular function of MidA was studied by
bioinformatics and site-directed mutagenesis. The results indicate
the presence in this protein family (DUF185) of a methyltransferase
fold, suggesting that methylation has an important role in CI
function. The phenotypic outcome observed in the Dictyostelium
midA– null mutant reveals the complexity of CI mitochondrial
disease and the contribution of AMPK signaling.
Results
Dictyostelium and human MidA mitochondrial proteins are
required for complex I activity
Dictyostelium and human MidA are highly homologous proteins.
Our previous studies in Dictyostelium showed that MidA is a
mitochondrial protein involved in bioenergetics and its high
sequence homology among species suggested the possibility of
functional conservation between humans and Dictyostelium (Torija
et al., 2006b). We wanted to test this hypothesis and extend our
knowledge of the function of these proteins. Consequently, our
first aim was to determine the subcellular localization of MidA in
human cells. A construct expressing the human protein fused to
GFP was transiently transfected into HeLa and HEK293T cells,
which were then stained with the mitochondria-specific dye
Mitotracker Red. As shown in supplementary material Fig. S1,
human MidA was also localized in mitochondria.
We next took advantage of comparative genomic tools to design
working hypotheses about MidA function. There are homologues
of MidA in many organisms but it seems to be absent in others and
this phylogenetic profile might provide important functional clues.
It is expected that proteins working together in a given function
will have the same phylogenetic profile. Using the String server
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(http://string.embl.de/), we obtained very similar phylogenetic
profiles for CI subunits, well known CI assembly factors and
MidA. A more detailed analysis using a wide array of species is
shown in supplementary material Table S1. There is a clear
correlation between the presence of MidA and a representative
complex I subunit (NDUFS7). It is well known that CI is not
present in all eukaryotes (such as fermentative yeasts S. cerevisiae
and S. pombe) but it is present in higher eukaryotes and
Dictyostelium where it has a key role in ATP generation. As
expected, MidA has no homologues in S. cerevisiae and S. pombe.
Interestingly, MidA homologues are also found in -proteobacteria,
the closest living organisms to the putative precursors of eukaryote
mitochondria.
To test the hypothesis of a functional connection between MidA
and CI, we measured the activity of the OXPHOS complexes (I,
II, III and IV) in Dictyostelium midA– null cells. A 50% decrease
in the activity of CI in Dictyostelium was observed (Fig. 1A).
Interestingly, the activity of the other complexes was either
unaffected or was significantly higher in the mutant. This might be
explained by a compensatory response to the loss of CI activity.
Fig. 1. The activity of complex I is reduced in cells lacking MidA.
(A)Spectrophotometric analysis of the activity of complexes I, II, III and IV in
Dictyostelium WT and midA– mutant cells. At least three independent
experiments for each complex were performed and the bars represent mean ±
s.d. Significance of differences were determined by Student’s t-test; *P<0.05;
**P<0.01; ***P<0.001; n.s., non-significant difference. Reduced activities of
complex I were observed in midA– Dictyostelium cells. CSA, complex specific
activity, corrected by citrate synthase. (B)The steady-state levels of expression
of representative genes from the eight major polycistronic transcripts from
mitochondrial RNA were measured and compared with the levels found in
wild-type control cells. Five of them showed significant increases compared
with wild-type cells. Three independent experiments were performed and the
bars represent the mean ± s.d. Significance of differences were determined by
Student’s t-test and indicated by the P value, as described above. (C)The level
of the activity of the mitochondrial enzyme citrate synthase (CS) and amount
of mtDNA was measured and compared with the wild type (adjusted to 100%).
Three independent experiments were performed and the statistical analysis
was carried out as described above.
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Consistent with this possible compensatory response, increases
were also observed in the mutant in the steady state levels of
mtDNA and most mtRNA transcripts (Fig. 1B,C). There also
appeared to be a small, albeit statistically insignificant, increase in
the activity of citrate synthase (Fig. 1C).
The level of assembled complex I is reduced in HEK293T
cells where MidA is downregulated
We next wanted to study the level of assembled complex I by blue
native (BN)-PAGE. We were unable to use Dictyostelium cells in
these analyses owing to the lack of available antibodies to detect
the different complexes and the low signal obtained by BN-PAGE.
Therefore we used stable transfectants of HEK293T cells in which
human MidA was downregulated by shRNAmir technology. Two
different clones (S1 and S19) were obtained with a level of MidA
mRNA downregulation of 93% and 87%, respectively. A control
clone transformed with a scrambled vector showed no reduction in
MidA mRNA. Fig. 2A shows representative gels and Fig. 2B a
quantification by densitometry of three independent experiments
where the level of CI had been normalized using the signal of
complex III. Similar results were obtained when we normalized for
complex II, complex IV and complex V (data not shown). We
found a modest effect in fully assembled CI that ranged from 60%
to 80% with respect to the control, which was treated with
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scrambled shRNA. The activity of CI was also measured by
spectrophotometric analysis. A reduction in CI activity was only
detected in clone S1, which had higher levels of mRNA inhibition.
This clone showed an average CI activity that was 75% of that in
control cells (data not shown). Together, these results suggest that
both Dictyostelium and human MidA are involved in complex I
assembly or stability.
MidA interacts with complex I subunit NDUFS2
In a parallel approach to elucidate the function of MidA, we
performed a yeast two-hybrid screening to identify possible
interactors. As bait we used the whole Dictyostelium MidA protein,
except for the first 21 amino acids, which correspond to the putative
mitochondrial targeting sequence. The vector used was pB29,
which contains an N-bait-LexA-C fusion, and 57.4 million
interactions were analyzed. Interestingly, ten independent positive
clones were obtained that encode Dictyostelium NADH-ubiquinone
oxidoreductase-chain 49 (DDB_G0294030), a homologue of the
human complex I subunit NDUFS2. Fig. 3A shows the common
region contained in the different clones that allowed us to restrain
the minimal interaction region to 40 amino acids. This interaction
was ranked with high confidence by a computer program (Global
PBS®, Predicted Biological Score from Hybrigenics) that represents
the probability of an interaction to be non-specific (Rain et al.,
2001). Nevertheless, a further validation was performed using pull-
down assays. The N-terminal fragment of Dictyostelium NDUFS2,
which contains the minimal region of interaction, was fused to
GST, purified from bacteria and incubated with cell extracts from
Dictyostelium expressing MidA fused with GFP. As shown in Fig.
3B, MidA-GFP was pulled down by GST-NDUFS2 but not by
GST alone, which was used as a control. We also wanted to
validate this interaction using human MidA, expressed in HEK293T
cells fused with GFP. The bacterially expressed N-terminus of
human NDUFS2 was used in the assay (Fig. 3B). A positive pull-
down was observed, again suggesting a functional conservation
between Dictyostelium and human MidA proteins.
We next asked whether the observed interaction requires the
functional methyltransferase domain identified in the MidA
sequence (see below). We performed pull-down assays using
Dictyostelium cell extracts expressing wild-type and mutated MidA
(G170V) in which the methyltransferase domain is presumed to be
inactivated (see below). As shown in Fig. 3C, both proteins were
pulled down by the bacterially expressed Dictyostelium NDUFS2,
suggesting that a functional methyltransferase domain is not
required for the interaction.
Is MidA stably bound to CI or any other large subcomplex? To
answer this question, we used the same Dictyostelium rescued
strain used in the pull-down experiments that stably expressed
MidA-GFP to perform a second-dimension analysis. After BN-
PAGE, the lane was cut and resolved in a second SDS-denaturing
dimension and MidA-GFP was detected by western blot analysis
(supplementary material Fig. 2B). MidA had an apparent molecular
size in the first dimension that was compatible with it being a
homodimer (approximately 200 kDa, after taking into account the
size of the GFP and TAP tags). Although most of the MidA protein
is present as a dimer, a signal was also detected at higher molecular
sizes (ranging from 450 to 750 kDa) (supplementary material Fig.
S2B). Dictyostelium CI has an approximate molecular weight of
880 kDa, as determined previously by MALDI-TOF analysis of
the corresponding band from BN-PAGE gels (supplementary
material Fig. S2A). Therefore, Dictyostelium MidA does not seem
Fig. 2. Reduction of fully assembled complex I in human cells with
downregulated MidA. (A)Mitochondrial complexes from human HEK293T
clones S1 and S19, and control cells were extracted with N-dodecyl -D-
maltoside for BN-PAGE analysis. The gel was transferred to PVDF membrane
and incubated with a cocktail of antibodies for complex detection. The
different bands were assigned by the expected pattern and their approximate
size calculated using a protein size standard. A significant reduction in CI
levels (indicated by rectangle) was observed. (B)Densitometric quantification
of three different BN-PAGE western blots showed a reduction of assembled CI
to approximately 70-80% of that found in a clone harboring a scrambled
vector. Densitometry was performed with ImageJ 1.33u (NIH, USA), and the
values for CI were normalized to those of complex III. The bars represent
mean ± s.d. P0.060 for S1 and P0.033 for S19 (Student’s t-test).
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to be stably bound to CI, but might be present in high molecular
mass CI subcomplexes. This is in agreement with previous
proteomic studies that have not detected MidA as part of CI
(Fearnley et al., 2007). A similar experiment was performed with
HEK293T expressing human MidA-GFP and we found no stable
association of the human protein with subcomplexes, although its
size suggested that it is also a homodimer (data not shown). Perhaps
the interaction of the Dictyostelium protein in large complexes is
more stable than that of the human homologue, allowing its
1677MidA is required for CI function
detection by this technique, or there might be functional differences
between species that we do not yet understand.
MidA has a conserved methyltransferase fold
The lack of obvious functional motifs in MidA amino acid
sequences prevented us from speculating about the possible
molecular function (Torija et al., 2006b). We have now searched
for structural similarities with other proteins whose function is
known and carried out bioinformatics modeling. To obtain a
structural model for MidA, we performed an initial Blast search
against PDB, the database of protein structures, to find a
homologous protein of known structure (Altschul et al., 1997;
Kirchmair et al., 2008). We found a highly similar candidate with
32% sequence identity with MidA and a Blast E-value of 2e-52.
This protein belongs to Rhodopseudomonas palustris and is a
target of a structural genomics consortium (Uniprot code Q6N1P6,
PDB code: 1zkd). Its function is still unknown, as shown by its
placement in the PFAM database of conserved domains as a
DUF185 member, a family of proteins of unknown function (Finn
et al., 2008). However, in the SCOP database of the structural
classification of proteins (Andreeva et al., 2008), 1zkd was
classified as a possible member of the S-adenosyl-L-methionine
(SAM)-dependent methyltransferases, a large superfamily of
proteins that is comprised of 52 protein families.
Using 1zkd as a template, a 3D model of MidA was built using
the Phyre server (Kelley and Sternberg, 2009). From the set of
models returned by this server, the one at the top of the list uses
1zkd as template, reflecting once more the relatedness of the two
proteins. The sequence-to-structure alignment between MidA and
1zkd covered most of the MidA sequence (Fig. 4A). Of course, the
MidA N-terminal sequence corresponding to the putative
mitochondrial-targeting peptide, is totally excluded in the model.
We next wanted to define the functional residues that might
occur in the catalytic site using FireStar (Lopez et al., 2007), a web
server that predicts functionally important residues using FireDB
(Lopez et al., 2007). FireDB is a database of PDB structures and
their associated ligands, and contains the largest set of reliably
annotated functionally important residues. These annotations are
extracted from protein-ligand atom contacts and are also derived
from the catalytic-site atlas (CSA) (Porter et al., 2004). Interestingly,
the information obtained from FireStar indicated a relationship
between the sequence of MidA and a human dimethyladenosine
transferase (PDB code 1zq9, chain A). Following the FireStar
annotations derived from the CSA, the catalytic site of 1zq9
contains three relevant residues: G64, E85 and N128. The two first
are conserved in MidA (G170 and E200), whereas the third is
replaced by a glutamine (Q257). The structure of the human
dimethyladenosine transferase (1zq9) is available (PDB code 1zq9,
chain A) and lzq9 was crystallized with S-adenosylmethionine
(SAM), the methyl donor, that was in contact with these three
residues. We superimposed our MidA 3D model with the region
that contains the 1zq9 catalytic site (residues 64-128) using local-
global alignment (LGA) (Zemla, 2003), and found that they
superimposed fairly well, as shown in Fig. 4B.
To determine whether the SAM ligand can be accommodated in
our MidA model in the proper manner, a docking was performed
using the Haddock biomolecular docking software by searching
1000 models. The only spatial restriction imposed on Haddock
was to keep SAM close to the equivalent three residues in our
model. We obtained several clusters of models, and finally selected
the first ten models of the best cluster. These models had good
Fig. 3. MidA interacts with NDUFS2. (A)A yeast two-hybrid screening
using Dictyostelium MidA as bait rendered a possible interaction with the N-
terminus of the complex I core subunit NDUFS2. The open rectangle
represents the complete amino acid sequence of Dictyostelium NDUFS2 and
the lines below mark the position and the number of the different clones that
gave a positive interaction in the screening. The amino acid sequence of the
overlapping minimal region is also shown. (B)The interaction was validated
by pull-down assay using bacterially expressed NDUFS2 fused with GST and
cell extracts expressing Dictyostelium MidA and human MidA fused to GFP. A
fraction of the bacterially expressed proteins used in the assay are shown by
Coomassie blue staining after SDS-PAGE electrophoresis. Human NDUFS2
was sensitive to degradation and little protein was obtained (labeled with an
asterisk). After incubation with the indicated cell extracts and subsequent
washes, the samples were separated by SDS-PAGE, transferred and incubated
with anti-GFP antibody. Both Dictyostelium and human MidA-GFP were
efficiently pulled down and showed the expected molecular size. (C)Similar
pull-down assays were performed using Dictyostelium cell extracts expressing
MidA-GFP as before, or a mutated form (G170V), indicated as MidA-GFP
(Mut1). A wild-type extract was used as an additional negative control. The
lower blot shows the bacterially expressed proteins used in the assay stained
with Coomassie blue. The upper blot shows both proteins interacting with
NDUFS2.
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Haddock scores and were very similar, with a maximum interface
ligand RMSD of 1.5 Å. The first ranked model is shown in Fig.
4C. The network of contacts between MidA and SAM remained,
as shown with Ligplot (Wallace et al., 1995) in supplementary
material Fig. S3, keeping the three aforementioned residues in
contact with SAM.
The next step was to simulate the effect of the mutation G170V.
We first replaced G170 with a valine with PyMol over the docking
model (The PyMol Molecular Graphics System, DeLano Scientific,
Palo Alto, CA) by selecting the rotamer that appears to be more
frequent in proteins. Obviously, the effect of this mutation produced
new clashes and so required a new docking of SAM with respect
to the mutated model. We ran Haddock again to better accommodate
the SAM molecule. Once more, we picked the first ten models of
the best cluster, and checked the level of conservation of the spatial
distance with respect to the three aforementioned residues in the
1678 Journal of Cell Science 123 (10)
mutation model. The new docking model allowed us to determine
that the initial network of contacts was lost, and that SAM was
now accommodated towards the exterior of the protein, presumably
causing a loss of the function of the enzyme. This was confirmed
experimentally by site-directed mutagenesis, as described below.
The crystal structure of 1zq9 indicates that the protein is
homodimeric, as described for other methyltransferases. It should
be noted that the BN- and SDS-PAGE analysis described above
suggested that MidA is also a dimer (supplementary material Fig.
S2).
The methyltransferase domain is required for MidA
function
The structural model shown above strongly suggested the presence
of a SAM-binding motif, which is characteristic of
methyltransferases. To confirm this hypothesis, we performed site-
directed mutagenesis to change residue G170, which is present in
the conserved folding and whose change to valine was predicted
to have a deleterious effect on the binding of SAM. A double
mutation was also performed to change both G170 and G172 to
valines. Both residues have been previously suggested to be
important for SAM binding, and are well conserved among
methyltransferases (Niewmierzycka and Clarke, 1999). The WT
and mutated forms of MidA were fused to GFP to monitor their
expression and localization in the cells and transformed into the
Dictyostelium midA– null mutant (Fig. 5A). As described previously,
midA– cells show defects in growth both in axenic medium and in
association with bacteria, as a consequence of the mitochondrial
dysfunction (Torija et al., 2006b). Although the WT protein
complemented the phenotype completely, the G170 mutated protein
was not able to complement the phenotype (Fig. 5C). A similar
result was obtained for the G170 and G172 double mutation (data
not shown). To exclude the possibility that the lack of
complementation was a result of failed targeting to the
mitochondria, we checked and showed that the proteins were
localized in the mitochondria (Fig. 5B shows the result for the
G170V mutant as an example). The lack of reversion of the
phenotype strongly suggests that a single mutation in G170 from
the methyltransferase domain is sufficient to render the protein
inactive. These results also suggest that the putative
methyltransferase domain is required for MidA function in
Dictyostelium.
Characterization of MidA complex I deficiency and its
relationship with AMPK signaling
To gain a better understanding of the genotype-phenotype
relationship in mitochondrial dysfunction, we made use of
Dictyostelium cells lacking MidA (midA– null mutant) as a cellular
model for CI disease. We wanted to characterize in detail the
phenotype of the null mutant and to study the relationship with
AMPK signaling. Dictyostelium cells aggregate upon starvation to
form a multicellular organism. At the slug stage, these structures
show a remarkable capacity to move towards light and thermal
gradients. This phototaxis and thermotaxis ability was shown to be
more sensitive to mitochondrial dysfunction than other cellular
functions (Kotsifas et al., 2002; Wilczynska et al., 1997). The
midA– mutant showed a strong defect in phototaxis, as observed by
the slug-trail assay (Fig. 6A, upper panel) and quantification of the
accuracy of phototaxis () (Fig. 6A, lower panel).  measures how
concentrated the trails are around the direction of the light source.
It ranges from 0 when there is no orientation in any preferential
Fig. 4. MidA contains a methyltransferase domain. (A)A 3D model of
MidA was built using as a template 1zkd, a Rhodopseudomonas palustris
protein that belongs to DUF185 family. The blue diagram represents 1zkd,
chain A from PDB (this protein is a homodimer and chain B is not displayed).
The orange diagram shows the MidA model. The structural alignment between
MidA and 1zkd is shown on the right and covers most of the MidA sequence.
(B)Detail of the alignment of the MidA model and 1zq9. The catalytic region
of the 3D model of MidA (orange) superimposes fairly well with that of 1zq9
(blue), a human dimethyladenosine transferase whose structure is known,
showing a characteristic fold exposing a loop where several conserved
residues reside. Among them, Gly170, was chosen for functional analysis.
(C)The methyl donor SAM fits in the MidA model. Docking was performed
running Haddock. SAM maintains the correct distances to the equivalent
critical residues of the methyltransferase 1zq9. Residues G170, E200 and
Q257 are blue and SAM is colored in green.
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direction to infinity in the case of a perfect orientation. The defect
in phototaxis was restored in a midA– mutant strain where
Dictyostelium MidA had been transformed with an expression
vector under the control of an actin promoter (rescued strain).
Similarly, a defect in thermotaxis was also observed, as shown in
Fig. 6B where  was measured in the wild type, the midA– mutant
strain and the rescued strain during thermotaxis at different
temperatures (Fig. 6B). Thermotaxis was also complemented in
the rescued strain. Additionally, midA– mutants showed a growth
defect that is accompanied by a phagocytosis and macropinocytosis
defect, as previously described (Torija et al., 2006b) and shown in
supplementary material Fig. S6. These defects in phagocytosis and
macropinocytosis have not been observed previously in other
mitochondrial Dictyostelium mutants, suggesting a more complex
scenario, which will be discussed below (Barth et al., 2007).
We next explored the contribution of AMPK signaling in the
complex phenotype of midA– cells. Overexpression of an AMPK
antisense construct has been previously shown to inhibit the
expression of AMPK and to restore phototaxis in several
Dictyostelium mutants. As expected, we found that phototaxis and
partly thermotaxis were restored in the midA– mutant when AMPK
was downregulated suggesting that this phenotype is mediated by
1679MidA is required for CI function
Fig. 5. Site-directed mutagenesis supports the presence of a
methyltransferase domain. (A)Scheme of the expression constructs used for
complementation studies. The coding region of the midA gene, fused to GFP
and TAP (tandem affinity purification tag), is directed by the Actin15 (A15)
promoter and is depicted as open boxes. A thin line represents an intron near
the N-terminus. Site-directed mutagenesis was performed at the indicated
residues (asterisk). (B)The wild-type and mutated constructs were transformed
in the midA– mutant and stable transformant clones were checked for
expression and localization of MidA in mitochondria. All the constructs
showed mitochondrial localization of the protein. A representative analysis is
shown for the mutated construct (G170V). Colocalization was observed
between MidA-GFP (green) and mitotracker (red), indicating mitochondrial
localization. Scale bar: 10m. (C)Analysis of growth in association with
bacteria of transformant clones with WT and the mutated forms of MidA. The
WT construct complemented the growth phenotype and other aspects of the
phenotype (not shown). However, the constructs containing the indicated
mutations were not able to complement the phenotype, giving rise to the small
colony phenotype that is characteristic of midA– mutant. A representative
analysis is shown for the mutation G170V. Scale bar: 1 cm.
Fig. 6. Phototaxis defects in DictyosteliumMidA mutant can be rescued by
AMPK inhibition. (A)Different Dictyostelium strains were allowed to form
migrating slugs and exposed to lateral light to determine their phototaxis
capabilities. The strains used were the following: wild-type Dictyostelium cells
(AX4), the midA-null mutant (midA–), a complemented strain ectopically
expressing the complete midA gene (midA– Rescue) and several independent
transformants (strain designations beginning with HPF) of the MidA mutant
expressing different numbers of copies of an AMPK antisense construct
(midA– AMPKAS). The copy number for the AMPK antisense construct
(pPROF362) is indicated within brackets. The phototaxis and migration (short
trails) defects of the midA– mutant were suppressed in a copy number-
dependent manner. In the lower panel, the accuracy of phototaxis () was
measured for the indicated strains at different cell densities. In this experiment,
the midA– AMPKAS strain was HPF722. (B)Defective thermotaxis in the
midA– mutant is complemented by ectopic expression of MidA and suppressed
by AMPK antisense inhibition. The accuracy of thermotaxis in a 0.2°C/cm
gradient was measured for slugs formed at a density of 3106 cells/cm2 and
migrating at temperatures ranging from 1 to 8 (arbitrary units corresponding in
separate calibration experiments to 14°C to 28°C). The midA– AMPKAS strain
was HPF723 and it exhibited substantial (but not complete) suppression of the
thermotaxis defect. Other details are as for A.
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a chronic activation of the kinase (Fig. 6A). This is the first report
that a phenotypic defect caused by a specific CI deficiency in a
model system can be rescued by AMPK downregulation.
Interestingly, the defects in growth, phagocytosis and
macropinocytosis were not rescued by the same experimental
manipulation, suggesting that these defects are independent of
AMPK signaling in the midA– mutant (supplementary material
Fig. S4).
Discussion
We used bioinformatics and experimental comparative analysis in
Dictyostelium and human cells to shed light on the function of
MidA, a protein that is conserved from bacteria to humans and
contains a characteristic DUF185 motif of unknown function. The
functional similarities between Dictyostelium MidA and its human
homologue strongly suggest that both proteins are orthologous
proteins that contain a methyltransferase domain and required for
mitochondrial CI function. Another putative methyltransferase has
recently been described to function in CI assembly or stability
(Gerards et al., 2009; Sugiana et al., 2008), highlighting the
potentially important but poorly understood role of methylation in
CI function.
About 40% of inherited disorders of the OXPHOS system
involve isolated or combined deficiencies in CI, the largest complex
of the OXPHOS system. The genetic cause of many cases of CI
deficiencies is still unknown, which is due in part to insufficient
understanding of the CI assembly process and the factors involved.
We do not know yet whether MidA is involved in human
mitochondrial disorders, but it should definitely be considered a
strong candidate. The loss of function of this protein in the model
Dictyostelium generates a complex phenotypic outcome, including
growth and developmental defects. In humans, disorders associated
with CI dysfunction are also complex, and usually lead to
multisystem failure that affects the brain, skeletal muscle and heart.      
Dictyostelium midA– null cells showed a decreased activity of
CI, and BN-PAGE studies in human cells where MidA is
downregulated also showed lower amounts of fully assembled
complex, suggesting a role for MidA as an assembly or stability
factor. The level of the assembly and activity of human CI in the
knockdown cells was around 70% of the control values, a moderate
effect but near the threshold that could have an impact in cellular
bioenergetics (Pathak and Davey, 2008), or even cause human
disease (Loeffen et al., 2001). CI is formed by a large number of
subunits (up to 45 subunits in humans). The assembly and stability
of such a large multiprotein complex requires specific chaperone
and assembly factors, six of which have been implicated in human
CI deficiency, including NDUFAF1-NDUFAF4 (Hoefs et al., 2009;
Ogilvie et al., 2005; Saada et al., 2009; Vogel et al., 2005),
C8ORF38 (Pagliarini et al., 2008) and C20ORF7 (Gerards et al.,
2009; Sugiana et al., 2008). Others such as Ecsit (Vogel et al.,
2007), AIF (Vahsen et al., 2004) and IndI (Bych et al., 2008) are
required for CI assembly, but have not yet been implicated in
human disease.
In spite of its large size, CI has a basic catalytic core formed by
only 14 proteins that are evolutionarily conserved from prokaryotes
to humans. All have been implicated in human CI disorders,
including NDUFS2 (Loeffen et al., 2001; Ugalde et al., 2004), an
iron-sulfur protein that we have shown to interact with
MidA/PRO1853. NDUFS2 is encoded by the nuclear genome of
human cells but it is encoded by the mitochondrial genome in
Dictyostelium revealing its ancient origin as an endosymbiont
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protein. Interestingly, MidA homologues also exist in -
proteobacteria, suggesting that the interplay between MidA protein
and the catalytic CI is of ancient origin and conserved from bacteria
to humans.
The SAM-dependent methyltransferase enzymes share little
sequence identity, but do contain a highly conserved structural fold
that is involved in SAM binding. Surprisingly, the precise residues
that bind the SAM cofactor are poorly conserved (Loenen, 2006;
Schubert et al., 2003). We have shown by bioinformatics modeling
and site-directed mutagenesis that DUF185 might have a
methyltransferase domain. At the level of amino acid sequence,
only a short region of homology can be detected between DUF185
proteins and methyltranferases, the so-called motif I, corresponding
to a loop of the catalytic core involved in SAM binding
(Niewmierzycka and Clarke, 1999). The consensus sequence was
defined as a nine-residue block, hh(D/E)hGxGxG, where h
represents a hydrophobic residue and x can be any residue
(Kakebeeke et al., 1979; Niewmierzycka and Clarke, 1999). In
previous studies based on multiple protein alignments, this short
sequence was revealed and led to the proposal that DUF185 is a
methyltransferase (Sadreyev et al., 2003). Our site-directed
mutagenesis studies targeted the first two conserved glycines
present in this sequence and showed that the first and possibly both
of these residues are required for the protein function. Five different
structural folds have been described to bind SAM and perform a
methyl transfer. Our model fits with class I, the most abundant,
which is composed of alternating -strands and -helices (Martin
and McMillan, 2002; Schubert et al., 2003). Taken together, these
studies strongly suggest that MidA proteins contain a
methyltransferase domain. The characterization of its biochemical
activity and the identification of the possible targets are of great
interest and will warrant further investigation.
Methyltranferases are a large family of proteins that are
involved in methylation of a wide variety of substrates including
DNA, RNA and proteins and the atomic targets can be carbon,
oxygen, nitrogen and sulfur. However, in most cases, no specific
traits in the sequence or the structure can be reliably used to
predict the substrate of the modification. Indeed, motif I is present
in DNA, RNA, protein and small molecule methyltransferases
(Kagan and Clarke, 1994). In mitochondria, methylation has an
essential role. Mitochondrial DNA, tRNA and rRNA are all
targets of specific methylation events (Helm et al., 1998; Pintard
et al., 2002) and specific carriers transport SAM into the
mitochondria (Agrimi et al., 2004). As far as protein methylation
is concerned, only two methylated subunits have been detected
in complex I subunits. One of them is the bovine NDUFB3
(B12), which is methylated at conserved His residues.
Interestingly, the other one is the human NDUFS2, which harbors
a methylated arginine, R323. Of course, the interaction of MidA
with NDUFS2 and subsequent methylation of the subunit is an
attractive hypothesis that remains to be investigated. The possible
functional relevance of NDUFS2 methylation is not known but it
is likely that this post-translational modification in such an
important core subunit alters the assembly or the stability of the
whole complex. In fact mutations in Arg228, Ser413 and Pro229
of NDUFS2 have been described to be involved in CI disease
(Loeffen et al., 2001). However, we should also consider the
possibility that MidA has a dual function as a chaperone and as
a methyltransferase. MidA is not stably bound to CI, as suggested
by our results using BN-PAGE. Therefore, it is possible that the
interaction with NDUFS2 occurs during the assembly process of
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the complex, thus functioning as a transitory step that is required
for correct CI stability.
The complex phenotypes of Dictyostelium cells deficient in
MidA show similarities with other strains with mitochondrial
disease, but there are also differences. Defects in phototaxis and
thermotaxis have been described previously in other Dictyostelium
mitochondrial dysfunctions that affect respiration, such as ethidium-
bromide-mediated mtDNA depletion and the antisense inhibition
of Chaperonin 60 (Cpn60) (Bokko et al., 2007; Chida et al., 2004;
Kotsifas et al., 2002; Wilczynska et al., 1997). Interestingly, the
phototaxis impairment in the MidA mutant can be rescued by
AMPK inhibition, similarly to the other described mitochondrial
mutants. However, midA– cells showed a severe defect in
phagocytosis and macropinocytosis: a phenotype that is not rescued
by AMPK antisense inhibition and is not even present in the other
described mitochondrial mutants. This defect would, in turn, explain
the AMPK-independent impairment of growth that we observe in
the MidA-null mutant. The results suggest that either MidA itself
or CI activity are specifically required for normal phagocytosis and
pinocytosis.
We observed compensatory responses that increased the
expression and level of activity of other respiratory chain complexes
and the amount of mtDNA in the cells. This suggests a feedback
that stimulates mitochondrial biogenesis and ATP production, but
fails to correct the specific CI deficiency caused by the absence of
MidA. AMPK might participate in this feedback, because it
stimulates mitochondrial biogenesis and ATP production in
Dictyostelium, as in other organisms (Bokko et al., 2007). The
pattern of phenotypic outcomes in the MidA-null mutant thus
results from both chronic AMPK activity and a specific failure of
the associated feedbacks to correct the CI deficiency. This reveals
once more the complexity of mitochondrial cytopathology and
specifically in CI diseases. The observation of the role played by
AMPK signaling in complex I pathology in Dictyostelium suggests
that in humans some of the associated phenotypes might also be
mediated by chronic activation of this signaling pathway. If so,
treatment aimed to regulate AMPK signaling might be beneficial.
Materials and Methods
Dictyostelium growth, transformation and development
Dictyostelium AX4 cells were grown axenically in HL-5 medium or in association
with Klebsiella aerogenes in SM plates (Sussman, 1987). Transformations were
carried out by electroporation, as described previously (Pang et al., 1999). For
synchronous development, axenically growing cells were washed from culture
medium by centrifugation, resuspended in water or PDF buffer and deposited on
nitrocellulose filters (Shaulsky and Loomis, 1993).
Human cell culture and RNA interference
HEK293T and HeLa cell lines were obtained from the American Type Culture
Collection (ATCC) (Manassas, VA) and were grown following the specifications of
the repository. Two different micro RNA adapted short-hairpin RNAs (shRNAmir)
cloned into pGIPZ vector (V2HLS_31857 and V2HLS_31862; Open Biosystems)
were used to stably knockdown the human gene encoding MidA (C2orf56).
Lipofectamine 2000 (Invitrogen) was used for transfection of the constructs according
to the manufacturer’s protocol. For selecting stable cell lines, the puromycin drug-
resistance marker was used. Relative quantitative real-time PCR was carried out to
estimate the knockdown levels of the human gene in a 7900HT Fast Real Time PCR
system (Applied Biosystems). For this purpose, two different TaqMan assays were
used. One specifically detected the levels of mRNA encoding MidA (Hs00218600;
Applied Biosystems). The other was a TaqMan ribosomal RNA control designed to
detect the 18S ribosomal RNA gene as endogenous control (4308329; Applied
Biosystems).
Mitochondrial localization
Mitochondrial localization with Mitotracker Red (Molecular Probes) was performed
as previously described (Torija et al., 2006b). Confocal analysis was performed in a
Leica TCS SP5 using a PL APO 63/1.4-0.6 objective and LAS-AF (Leica
Application Suite) software.
Spectrophotometric analysis of the OXPHOS complexes and BN-PAGE
For spectrophotometric analysis, 5107 growing cells were centrifuged and washed
once with PBS. The pellet was resuspended in 2 ml SETH buffer (250 mM sucrose,
2 mM EDTA, 10 mM Tris-HCl, 100 U/l heparin, pH 7.4) and then sonicated three
times in ice-cold water for 10 seconds with 30 second rests in between. To eliminate
cell debris, the sample was centrifuged and the supernatant was used as reaction
sample for spectrometric analysis, as previously described (Tiranti et al., 1995).
BN-PAGE analysis was basically performed as previously reported (Calvaruso et
al., 2008) with small changes. Briefly, 1107 cells were resuspended in 3 gel
buffer (750 mM aminocaproic acid, 150 mM Bis-Tris pH 7.0) and the amount of
protein quantified with the Bradford assay. N-dodecyl -D-maltoside (Sigma) was
added to a ratio 20 g per g total protein and made up to 40 l with 3 gel buffer.
40 g were loaded per lane for the CI detection, whereas 10 g were loaded for
MidA detection. For western blot analysis, the gel was transferred overnight at room
temperature to a 0.45 m PVDF membrane (PALL life sciences) at 30 V with 1
Tris-Gly, 20% methanol and 0.02% SDS buffer. Then, the membrane was stripped
with 2% SDS, 62.5 mM Tris-HCl, pH 6.8, for 90 minutes. The western blot was
carried out with total OXPHOS Human WB Antibody Cocktail (Mitosciences) to
assay CI stability. A protein standard (Invitrogene) was used to estimate the size of
the complexes. Secondary antibody goat anti-mouse IgG-HRP was provided by
Santa Cruz Biotechnology. For MidA dimer experiments, the second dimension was
made as previously described (Calvaruso et al., 2008). Anti-GFP (SIGMA) and goat
anti-rabbit IgG-HRP (Santa Cruz) antibodies were used.
Site-directed mutagenesis
Site-directed mutagenesis of G170V and G172V was performed by PCR using as
template the complete MidA gene cloned in pGEMt. Two complementary
oligonucleotides containing the desired mutations were used. For G170V: oligo 1,
CAA ATA GTT GAA ATG GTT CCA GGT AGA GGC ACA CTA ATG; oligo 2,
CAT TAG TGT GCC TCT ACC TGG AAC CAT TTC AAC TAT TTG. For double
mutation G170V and G172V: oligo 3, CAA ATA GTT GAA ATG GTT CCA GTT
AGA GGC ACA CTA ATG. Oligo 4, CAT TAG TGT GCC TCT AAC TGG AAC
CAT TTC AAC TAT TTG. The PCR reaction was digested with DpnI and transformed
into E. coli DH5 for plasmid amplification. The constructs were fully sequenced
to confirm the mutations and cloned in-frame with GFP in the vector pDV-CGFP-
CTAP, kindly provided by Pauline Shaap (University of Dundee, Dundee, UK). A
similar construct was used with a complete wild-type sequence of MidA.
Pull-down assays
The N-terminus of Dictyostelium and human genes encoding NDUFS2 were expanded
by PCR and cloned in PGEX plasmid (Pharmacia-Biotech) for bacterial expression
and subsequent purification by the GST system according to the manufacturer’s
instructions. The Dictyostelium NDUFS2 construct spanned amino acids 8-176 and
human NDUFS2 amino acids 38-234. GST alone was used as a control. The isolated
proteins were kept associated with the Sepharose beads until used in the pull-down
assay. 5106 Dictyostelium and HEK293T cells expressing Dictyostelium or human
MidA fused to GFP were resuspended in 500 l STE+T buffer (10 mM Tris-HCl,
pH 8, 1 mM EDTA pH 8, 150 mM NaCl, 5 mM DTT, 1% Triton X-100, 1 protease
inhibitor cocktail) and shaken for 30 minutes at 4°C. After centrifugation, the
supernatant was incubated with 30 l of previously isolated proteins bound to the
Sepharose beads for 1 hour at 4°C. Beads were washed three times with STE+T and
finally resuspended in 30 l protein loading buffer. The sample was split in two
SDS-PAGE gels. One was stained with Coomassie Blue as a control and the other
was transferred to PVDF for western blotting using anti-GFP antibody.
mtDNA and mtRNA quantification
For mtDNA quantification Dictyostelium cells were grown in HL-5 medium to log
phase. Genomic DNA from 6106 cells was extracted with 300 l Quick Extract
DNA Extraction Solution 1.0 (Epicentre). 1:50 dilution was used as a template in the
PCR reaction carried out in 7900 HT Fast Real-Time PCR System, using Power
Sybrgreen PCR Master Mix 2 with 300 nM oligonucleotides in a final volume of 10
l. Results were acquired with SDS 2.3 software by Applied Biosystems and handled
with Excel software by Microsoft. Two pairs of oligonucleotides were used: One for
detection of mtDNA (DDB_G0294054), oligo1, AAC AAT CAT GTG GCT TTA
GTA CGT AAA; oligo2, TCG GCC CTG CAT TTC GT and another for normalization
with a nuclear gene (DDB_G0277273). Oligo 1, CCG TTG CCC TAA CTT ACT
TCC A; oligo 2, GCC GCC ATT GAT GAA ACT ATT C. For mtRNA quantification,
RNA from 1107 cells growing to log phase in HL-5 medium was isolated with Tri-
Reagent (Sigma) and adjusted to 2 g/l final concentration. DNA contamination
was removed by adding 50 U DNase (New England Biolabs) to 10 g RNA in a
final volume of 10 l. The reaction was incubated for 30 minutes at 37° C following
an incubation at 70°C for 5 minutes to destroy DNase activity. The RNA was then
adjusted with DEPC water to 100 ng/l final concentration. 250 ng (2.5 l) of this
RNA was used as a template for RT-PCR with high capacity cDNA reverse
transcription kit (Applied Biosystems) in a final volume of 20 l. The cDNAs served
as template in the PCR reaction carried out as described above. Eight genes
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representative of the previously described eight major polycistronic transcripts (Barth
et al., 2001) were studied for each sample, normalized to the nuclear gene
DDB_G0277273 and referred to the wild-type levels. The oligonucleotides used are
listed in supplementary material Table S2.
Phototaxis and thermotaxis assays
Qualitative phototaxis tests were performed as described (Darcy et al., 1994) by
transferring a toothpick scraping of amoebae from a colony growing on a K.
aerogenes lawn to the center of charcoal agar plates (5% activated charcoal, 1%
agar). Phototaxis was scored after a 48 hour incubation at 21°C with a lateral light
source. Quantitative phototaxis tests involved the harvesting of amoebae from mass
plates, thoroughly washing them free of bacteria, suspending them in saline at the
appropriate dilutions and inoculating 20 l onto a 1 cm2 area in the center of each
charcoal agar plate. The resulting cell densities ranged from about 1.5106 to
3.7107 cells/cm2. The phototaxis was again scored after a 48 hour incubation at
21°C with a lateral light source. Quantitative thermotaxis used washed amoebae
prepared as for quantitative phototaxis and plated at a density of 3106 amoebae/cm2.
A 20 l aliquot of cells at this dilution was plated on a 1 cm2 area in the center of
water agar plates (1% agar) and incubated for 72 hours in darkness on a heat bar
producing a 0.2°C/cm gradient at the agar surface. The arbitrary temperature units
correspond to the temperatures 14°C at T1 and increasing in 2°C increments to 28°C
at T8, as measured at the center of plates in separate calibration experiments. Slug
trails were transferred to PVC discs, stained with Coomassie blue and digitized. The
orientation of the slug migration was analysed using directional statistics (Fisher,
1981).
Phagocytosis and pinocytosis assays
All Dictyostelium strains (wild type AX2, midA null mutant and the midA rescued
strain) were grown in HL-5 medium with no antibiotics to exponential phase before
use in the pinocytosis and phagocytosis experiments. Bacterial uptake by
Dictyostelium strains was determined by using as prey an E. coli strain expressing
fluorescent protein DsRed (Maselli et al., 2002) as previously described (Bokko et
al., 2007).
Pinocytosis assays (Klein and Satre, 1986) were performed by measuring the
uptake of medium containing a fluorescent indicator, fluorescein isothiocyanate
(FITC)-dextran (Sigma, average mol. mass 70 kDa), as previously described (Bokko
et al., 2007).
This work was supported by grants BMC2006-00394 and
BMC2009-09050 to R.E. from the Spanish Ministerio de Ciencia e
Innovación; to P.R.F. from the Thyne Reid Memorial Trusts and the
Australian Research Council; to A.V. and O.G. from the Spanish
National Bioinformatics Institute (www.inab.org), a platform of
Genome Spain; to R.G. from the Fondo de Investigaciones Sanitarias,
Instituto de Salud Carlos III, Spain (PI070167) and from the
Comunidad de Madrid (GEN-0269/2006). S.C. is supported by a
research contract from Consejería de Educación de la Comunidad de
Madrid y del Fondo Social Europeo (FSE). Sequence data for
Dictyostelium were obtained from the Genome Sequencing Centers of
the University of Cologne, Germany; the Institute of Molecular
Biotechnology, Department of Genome Analysis, Jena; Baylor Collage
of Medicine in Houston, Texas, USA; and the Sanger Center in
Hinxton, Cambridge, UK. Y2H screening was performed by
Hybrigenics (Paris, France). We thank Rosa M. Calvo for help with
several experiments, Susana Peralta for advice on BN-PAGE, Gloria
Fuentes for all the help with Haddock and Ana Rojas, Gonzalo López
and Michael L. Tress for their interesting suggestions.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/123/10/1674/DC1
References
Agrimi, G., Di Noia, M. A., Marobbio, C. M., Fiermonte, G., Lasorsa, F. M. and
Palmieri, F. (2004). Identification of the human mitochondrial S-adenosylmethionine
transporter: bacterial expression, reconstitution, functional characterization and tissue
distribution. Biochem. J. 379, 183-190.
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and
Lipman, D. J. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res. 25, 3389-3402.
Andreeva, A., Howorth, D., Chandonia, J. M., Brenner, S. E., Hubbard, T. J., Chothia,
C. and Murzin, A. G. (2008). Data growth and its impact on the SCOP database: new
developments. Nucleic Acids Res. 36, D419-D425.
Annesley, S. J. and Fisher, P. R. (2009a). Dictyostelium discoideum-a model for many
reasons. Mol. Cell Biochem. 329, 73-91.
Annesley, S. J. and Fisher, P. R. (2009b). Dictyostelium slug phototaxis. Methods Mol.
Biol. 571, 67-76.
Barth, C., Greferath, U., Kotsifas, M., Tanaka, Y., Alexander, S., Alexander, H. and
Fisher, P. R. (2001). Transcript mapping and processing of mitochondrial RNA in
Dictyostelium discoideum. Curr. Genet. 39, 355-364.
Barth, C., Le P. and Fisher, P. R. (2007). Mitochondrial biology and disease in
Dictyostelium. Int. Rev. Cytol. 263, 207-252.
Bokko, P. B., Francione, L., Bandala-Sanchez, E., Ahmed, A. U., Annesley, S. J.,
Huang, X., Khurana, T., Kimmel, A. R. and Fisher, P. R. (2007). Diverse
cytopathologies in mitochondrial disease are caused by AMP-activated protein kinase
signaling. Mol. Biol. Cell 18, 1874-1886.
Bych, K., Kerscher, S., Netz, D. J., Pierik, A. J., Zwicker, K., Huynen, M. A., Lill, R.,
Brandt, U. and Balk, J. (2008). The iron-sulphur protein Ind1 is required for effective
complex I assembly. EMBO J. 27, 1736-1746.
Calvaruso, M. A., Smeitink, J. and Nijtmans, L. (2008). Electrophoresis techniques to
investigate defects in oxidative phosphorylation. Methods 46, 281-287.
Carroll, J., Fearnley, I. M., Skehel, J. M., Runswick, M. J., Shannon, R. J., Hirst, J.
and Walker, J. E. (2005). The post-translational modifications of the nuclear encoded
subunits of complex I from bovine heart mitochondria. Mol. Cell Proteomics 4, 693-
699.
Chida, J., Yamaguchi, H., Amagai, A. and Maeda, Y. (2004). The necessity of
mitochondrial genome DNA for normal development of Dictyostelium cells. J. Cell Sci.
117, 3141-3152.
Darcy, P. K., Wilczynska, Z. and Fisher, P. R. (1994). Genetic analysis of Dictyostelium
slug phototaxis mutants. Genetics 137, 977-985.
Debray, F. G., Lambert, M. and Mitchell, G. A. (2008). Disorders of mitochondrial
function. Curr. Opin. Pediatr. 20, 471-482.
DiMauro, S. and Schon, E. A. (2008). Mitochondrial disorders in the nervous system.
Annu. Rev. Neurosci. 31, 91-123.
Eichinger, L., Pachebat, J. A., Glockner, G., Rajandream, M. A., Sucgang, R.,
Berriman, M., Song, J., Olsen, R., Szafranski, K., Xu, Q. et al. (2005). The genome
of the social amoeba Dictyostelium discoideum. Nature 435, 43-57.
Escalante, R. and Vicente, J. J. (2000). Dictyostelium discoideum: a model system for
differentiation and patterning. Int. J. Dev. Biol. 44, 819-835.
Fearnley, I. M., Carroll, J. and Walker, J. E. (2007). Proteomic analysis of the subunit
composition of complex I (NADH:ubiquinone oxidoreductase) from bovine heart
mitochondria. Methods. Mol. Biol. 357, 103-125.
Finn, R. D., Tate, J., Mistry, J., Coggill, P. C., Sammut, S. J., Hotz, H. R., Ceric, G.,
Forslund, K., Eddy, S. R., Sonnhammer, E. L. et al. (2008). The Pfam protein
families database. Nucleic Acids Res. 36, D281-D288.
Fisher, P. R., Smith, E. and Williams, K. L. (1981). An extracellular chemical signal
controlling phototactic behavior by D. discoideum slugs. Cell 23, 799-807.
Gerards, M., Sluiter, W., van den Bosch, B. J., de Wit, E., Calis, C. M., Frentzen, M.,
Akbari, H., Schoonderwoerd, K., Scholte, H. R., Jongbloed, R. J. et al. (2009).
Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh
syndrome. J. Med. Genet. PMID: 19452079.
Helm, M., Brule, H., Degoul, F., Cepanec, C., Leroux, J. P., Giege, R. and Florentz,
C. (1998). The presence of modified nucleotides is required for cloverleaf folding of a
human mitochondrial tRNA. Nucleic Acids Res. 26, 1636-1643.
Hoefs, S. J., Dieteren, C. E., Rodenburg, R. J., Naess, K., Bruhn, H., Wibom, R.,
Wagena, E., Willems, P. H., Smeitink, J. A., Nijtmans, L. G. et al. (2009). Baculovirus
complementation restores a novel NDUFAF2 mutation causing complex I deficiency.
Hum. Mutat. 30, E728-E736.
Janssen, R. J., Nijtmans, L. G., van den Heuvel, L. P. and Smeitink, J. A. (2006).
Mitochondrial complex I: structure, function and pathology. J. Inherit. Metab. Dis. 29,
499-515.
Kagan, R. M. and Clarke, S. (1994). Widespread occurrence of three sequence motifs in
diverse S-adenosylmethionine-dependent methyltransferases suggests a common
structure for these enzymes. Arch. Biochem. Biophys. 310, 417-427.
Kakebeeke, P. I. J., de Wit, R. J. W., Kohtz, S. D. and Konijn, T. M. (1979). Negative
chemotaxis in Dictyostelium and Polysphondylium. Exp. Cell Res. 124, 429-433.
Kelley, L. A. and Sternberg, M. J. (2009). Protein structure prediction on the Web: a case
study using the Phyre server. Nat. Protoc. 4, 363-371.
Kirchmair, J., Markt, P., Distinto, S., Schuster, D., Spitzer, G. M., Liedl, K. R.,
Langer, T. and Wolber, G. (2008). The Protein Data Bank (PDB), its related services
and software tools as key components for in silico guided drug discovery. J. Med.
Chem. 51, 7021-7040.
Klein, G. and Satre, M. (1986). Kinetics of fluid-phase pinocytosis in Dictyostelium
discoideum amoebae. Biochem. Biophys. Res. Commun. 138, 1146-1152.
Koopman, W. J., Nijtmans, L. G., Dieteren, C. E., Roestenberg, P., Valsecchi, F.,
Smeitink, J. A. and Willems, P. H. (2010). Mammalian mitochondrial complex I:
biogenesis, regulation and reactive oxygen species generation. Antioxid. Redox Signal.
PMID: 19803744.
Kotsifas, M., Barth, C., De Lozanne, A., Lay, S. T. and Fisher, P. R. (2002). Chaperonin
60 and mitochondrial disease in Dictyostelium. J. Muscle Res. Cell Motil. 23, 839-852.
Lazarou, M., Thorburn, D. R., Ryan, M. T. and McKenzie, M. (2009). Assembly of
mitochondrial complex I and defects in disease. Biochim. Biophys. Acta. 1793, 78-88.
Loeffen, J., Elpeleg, O., Smeitink, J., Smeets, R., Stockler-Ipsiroglu, S., Mandel, H.,
Sengers, R., Trijbels, F. and van den Heuvel, L. (2001). Mutations in the complex I
NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann. Neurol.
49, 195-201.
Loenen, W. A. (2006). S-adenosylmethionine: jack of all trades and master of everything?
Biochem. Soc. Trans. 34, 330-333.
Lopez, G., Valencia, A. and Tress, M. L. (2007). firestar-prediction of functionally
important residues using structural templates and alignment reliability. Nucleic Acids
Res. 35, W573-W577.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
1683MidA is required for CI function
Martin, J. L. and McMillan, F. M. (2002). SAM (dependent) I AM: the S-
adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12,
783-793.
Maselli, A., Laevsky, G. and Knecht, D. A. (2002). Kinetics of binding, uptake and
degradation of live fluorescent (DsRed) bacteria by Dictyostelium discoideum.
Microbiology 148, 413-420.
Niewmierzycka, A. and Clarke, S. (1999). S-Adenosylmethionine-dependent methylation
in Saccharomyces cerevisiae. Identification of a novel protein arginine methyltransferase.
J. Biol. Chem. 274, 814-824.
Ogawa, S., Yoshino, R., Angata, K., Iwamoto, M., Pi, M., Kuroe, K., Matsuo, K.,
Morio, T., Urushihara, H., Yanagisawa, K. et al. (2000). The mitochondrial DNA of
Dictyostelium discoideum: complete sequence, gene content and genome organization.
Mol. Gen. Genet. 263, 514-519.
Ogilvie, I., Kennaway, N. G. and Shoubridge, E. A. (2005). A molecular chaperone for
mitochondrial complex I assembly is mutated in a progressive encephalopathy. J. Clin.
Invest. 115, 2784-2792.
Pagliarini, D. J., Calvo, S. E., Chang, B., Sheth, S. A., Vafai, S. B., Ong, S. E., Walford,
G. A., Sugiana, C., Boneh, A., Chen, W. K. et al. (2008). A mitochondrial protein
compendium elucidates complex I disease biology. Cell 134, 112-123.
Pang, K. M., Lynes, M. A. and Knecht, D. A. (1999). Variables controlling the expression
level of exogenous genes in Dictyostelium. Plasmid 41, 187-197.
Pathak, R. U. and Davey, G. P. (2008). Complex I and energy thresholds in the brain.
Biochim. Biophys. Acta 1777, 777-782.
Pintard, L., Bujnicki, J. M., Lapeyre, B. and Bonnerot, C. (2002). MRM2 encodes a
novel yeast mitochondrial 21S rRNA methyltransferase. EMBO J. 21, 1139-1147.
Porter, C. T., Bartlett, G. J. and Thornton, J. M. (2004). The Catalytic Site Atlas: a
resource of catalytic sites and residues identified in enzymes using structural data.
Nucleic Acids Res. 32, D129-D133.
Rain, J. C., Selig, L., De Reuse, H., Battaglia, V., Reverdy, C., Simon, S., Lenzen, G.,
Petel, F., Wojcik, J., Schachter, V. et al. (2001). The protein-protein interaction map
of Helicobacter pylori. Nature 409, 211-215.
Remacle, C., Barbieri, M. R., Cardol, P. and Hamel, P. P. (2008). Eukaryotic complex
I: functional diversity and experimental systems to unravel the assembly process. Mol.
Genet. Genomics 280, 93-110.
Saada, A., Vogel, R. O., Hoefs, S. J., van den Brand, M. A., Wessels, H. J., Willems,
P. H., Venselaar, H., Shaag, A., Barghuti, F., Reish, O. et al. (2009). Mutations in
NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I
assembly protein, cause fatal neonatal mitochondrial disease. Am. J. Hum. Genet. 84,
718-727.
Sadreyev, R. I., Baker, D. and Grishin, N. V. (2003). Profile-profile comparisons by
COMPASS predict intricate homologies between protein families. Protein Sci. 12,
2262-2272.
Schubert, H. L., Blumenthal, R. M. and Cheng, X. (2003). Many paths to methyltransfer:
a chronicle of convergence. Trends Biochem. Sci. 28, 329-335.
Shaulsky, G. and Loomis, W. F. (1993). Cell type regulation in response to expression of
ricin-A in Dictyostelium. Dev. Biol. 160, 85-98.
Sugiana, C., Pagliarini, D. J., McKenzie, M., Kirby, D. M., Salemi, R., Abu-Amero,
K. K., Dahl, H. H., Hutchison, W. M., Vascotto, K. A., Smith, S. M. et al. (2008).
Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal
mitochondrial disease. Am. J. Hum. Genet. 83, 468-478.
Sussman, M. (1987). Cultivation and synchronous morphogenesis of Dictyostelium under
controlled experimental conditions. Meth. Cell Biol. 28, 9-29.
Tiranti, V., Chariot, P., Carella, F., Toscano, A., Soliveri, P., Girlanda, P., Carrara, F.,
Fratta, G. M., Reid, F. M., Mariotti, C. et al. (1995). Maternally inherited hearing
loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial
tRNASer(UCN) gene. Hum. Mol. Genet. 4, 1421-1427.
Torija, P., Robles, A. and Escalante, R. (2006a). Optimization of a large-scale gene
disruption protocol in Dictyostelium and analysis of conserved genes of unknown
function. BMC Microbiol. 6, 75.
Torija, P., Vicente, J. J., Rodrigues, T. B., Robles, A., Cerdan, S., Sastre, L., Calvo, R.
M. and Escalante, R. (2006b). Functional genomics in Dictyostelium: MidA, a new
conserved protein, is required for mitochondrial function and development. J. Cell Sci.
119, 1154-1164.
Ugalde, C., Janssen, R. J., van den Heuvel, L. P., Smeitink, J. A. and Nijtmans, L. G.
(2004). Differences in assembly or stability of complex I and other mitochondrial
OXPHOS complexes in inherited complex I deficiency. Hum. Mol. Genet. 13, 659-667.
Vahsen, N., Cande, C., Briere, J. J., Benit, P., Joza, N., Larochette, N.,
Mastroberardino, P. G., Pequignot, M. O., Casares, N., Lazar, V. et al. (2004). AIF
deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679-4689.
Vogel, R. O., Janssen, R. J., Ugalde, C., Grovenstein, M., Huijbens, R. J., Visch, H.
J., van den Heuvel, L. P., Willems, P. H., Zeviani, M., Smeitink, J. A. et al. (2005).
Human mitochondrial complex I assembly is mediated by NDUFAF1. FEBS J. 272,
5317-5326.
Vogel, R. O., Janssen, R. J., van den Brand, M. A., Dieteren, C. E., Verkaart, S.,
Koopman, W. J., Willems, P. H., Pluk, W., van den Heuvel, L. P., Smeitink, J. A.
et al. (2007). Cytosolic signaling protein Ecsit also localizes to mitochondria where it
interacts with chaperone NDUFAF1 and functions in complex I assembly. Genes Dev.
21, 615-624.
Wallace, A. C., Laskowski, R. A. and Thornton, J. M. (1995). LIGPLOT: a program to
generate schematic diagrams of protein-ligand interactions. Prot. Eng. 8, 127-134.
Wilczynska, Z., Barth, C. and Fisher, P. R. (1997). Mitochondrial mutations impair
signal transduction in Dictyostelium discoideum slugs. Biochem. Biophys. Res. Commun.
234, 39-43.
Williams, R. S., Boeckeler, K., Graf, R., Muller-Taubenberger, A., Li, Z., Isberg, R.
R., Wessels, D., Soll, D. R., Alexander, H. and Alexander, S. (2006). Towards a
molecular understanding of human diseases using Dictyostelium discoideum. Trends
Mol. Med. 12, 415-424.
Wu, C. C., MacCoss, M. J., Howell, K. E. and Yates, J. R., 3rd. (2003). A method for
the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 21, 532-
538.
Zemla, A. (2003). LGA: a method for finding 3D similarities in protein structures. Nucleic
Acids Res. 31, 3370-3374.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
